Antibodies against SARS-CoV-2 Suggestive of Single Events of Spillover to Cattle, Germany

被引：12
|
作者：
Wernike, Kerstin [1 ]
Boettcher, Jens [2 ]
Amelung, Silke [3 ]
Albrecht, Kerstin [4 ]
Gartner, Tanja [5 ]
Donat, Karsten [5 ]
Beer, Martin [1 ]
机构：
[1] Friedrich Loeffler Inst, Greifswald Insel, Greifswald, Germany
[2] Bavarian Anim Hlth Serv, Poing, Germany
[3] LUFA Nord West, Oldenburg, Germany
[4] State Inst Consumer Protect Saxony Anhalt, Stendal, Germany
[5] Anim Hlth Serv, Thuringian Anim Dis Fund, Jena, Germany
来源：
EMERGING INFECTIOUS DISEASES | 2022年 / 28卷 / 09期
关键词：
D O I：
10.3201/eid2809.220125
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Human infection with SARS-CoV-2 poses a risk for transmission to animals. To characterize the risk for cattle, we serologically investigated 1,000 samples collected from cattle in Germany in late 2021. Eleven antibody-positive samples indicated that cattle may be occasionally infected by contact with SARS-CoV-2-positive keepers, but we found no indication of further spread.
引用
收藏
页码：1916 / 1918
页数：3
相关论文
共 50 条
  • [1] SARS-CoV-2 spillover events
    Zhou, Peng
    Shi, Zheng-Li
    [J]. SCIENCE, 2021, 371 (6525) : 120 - 122
  • [2] Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of Germany
    Michelitsch, Anna
    Hoffmann, Donata
    Wernike, Kerstin
    Beer, Martin
    [J]. VACCINES, 2020, 8 (04) : 1 - 10
  • [3] Identification of Human Single-Domain Antibodies against SARS-CoV-2
    Wu, Yanling
    Li, Cheng
    Xia, Shuai
    Tian, Xiaolong
    Kong, Yu
    Wang, Zhi
    Gu, Chenjian
    Zhang, Rong
    Tu, Chao
    Xie, Youhua
    Yang, Zhenlin
    Lu, Lu
    Jiang, Shibo
    Ying, Tianlei
    [J]. CELL HOST & MICROBE, 2020, 27 (06) : 891 - +
  • [4] Neutralizing and enhancing antibodies against SARS-CoV-2
    Liu, Yafei
    Arase, Hisashi
    [J]. INFLAMMATION AND REGENERATION, 2022, 42 (01)
  • [5] Neutralizing and enhancing antibodies against SARS-CoV-2
    Yafei Liu
    Hisashi Arase
    [J]. Inflammation and Regeneration, 42
  • [6] Duration of SARS-CoV-2 Serum-Neutralizing Antibodies Against SARS-CoV-2 Dependent on the Individual
    Li, Jin
    Zou, Li
    Li, Shaojie
    Zou, Ruogu
    Fang, Zhixiong
    Zhang, Pingan
    Li, Huijun
    Wang, Shanshan
    Ke, Dong
    Gao, Peng
    Jin, Cuicui
    Fang, Cong
    Zhou, Ji
    He, Ellen
    Skog, Sven
    [J]. VIRAL IMMUNOLOGY, 2023, 36 (03) : 153 - 162
  • [7] A deadly spillover: SARS-CoV-2 outbreak
    Mori, Mattia
    Capasso, Clemente
    Carta, Fabrizio
    Donald, William A.
    Supuran, Claudiu T.
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2020, 30 (07) : 481 - 485
  • [8] Autoimmune Effect of Antibodies against the SARS-CoV-2 Nucleoprotein
    Matyushkina, Daria
    Shokina, Varvara
    Tikhonova, Polina
    Manuvera, Valentin
    Shirokov, Dmitry
    Kharlampieva, Daria
    Lazarev, Vasily
    Varizhuk, Anna
    Vedekhina, Tatiana
    Pavlenko, Alexander
    Penkin, Leonid
    Arapidi, Georgij
    Pavlov, Konstantin
    Pushkar, Dmitry
    Kolontarev, Konstantin
    Rumyantsev, Alexander
    Rumyantsev, Sergey
    Rychkova, Lyubov
    Govorun, Vadim
    [J]. VIRUSES-BASEL, 2022, 14 (06):
  • [9] Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
    Shay Reicher
    Ronit Ratzon
    Shay Ben-Sahar
    Sharon Hermoni-Alon
    David Mossinson
    Yotam Shenhar
    Michael Friger
    Yaniv Lustig
    Sharon Alroy-Preis
    Emilia Anis
    Siegal Sadetzki
    Ehud Kaliner
    [J]. European Journal of Epidemiology, 2021, 36 : 727 - 734
  • [10] The humoral response and antibodies against SARS-CoV-2 infection
    Hai Qi
    Bo Liu
    Xinquan Wang
    Linqi Zhang
    [J]. Nature Immunology, 2022, 23 : 1008 - 1020
12345